Mehrdad Ravanshad

455 total citations
52 papers, 352 citations indexed

About

Mehrdad Ravanshad is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mehrdad Ravanshad has authored 52 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 24 papers in Hepatology and 15 papers in Infectious Diseases. Recurrent topics in Mehrdad Ravanshad's work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (17 papers) and HIV Research and Treatment (12 papers). Mehrdad Ravanshad is often cited by papers focused on Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (17 papers) and HIV Research and Treatment (12 papers). Mehrdad Ravanshad collaborates with scholars based in Iran, United States and Belgium. Mehrdad Ravanshad's co-authors include Seyed Younes Hosseini, Sayyad Khanizadeh, Farzaneh Sabahi, Parivash Davoodian, Shahab Falahi, Seyed Dawood Mousavi Nasab, Mohammad Almasian, Jamal Sarvari, Seyed Reza Mohebbi and Reza Ghanbari and has published in prestigious journals such as Journal of Medical Virology, International Journal of Infectious Diseases and Liver International.

In The Last Decade

Mehrdad Ravanshad

48 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehrdad Ravanshad Iran 11 132 116 106 81 57 52 352
Sumudu Narayana Australia 7 171 1.3× 137 1.2× 134 1.3× 146 1.8× 38 0.7× 19 553
Shahab Mahmoudvand Iran 9 183 1.4× 152 1.3× 49 0.5× 113 1.4× 12 0.2× 32 428
Peter D. Block United States 8 230 1.7× 74 0.6× 197 1.9× 103 1.3× 29 0.5× 17 457
Nan L. Li United States 8 186 1.4× 157 1.4× 123 1.2× 127 1.6× 22 0.4× 9 542
Sreedhar Chinnaswamy India 12 123 0.9× 113 1.0× 177 1.7× 85 1.0× 22 0.4× 25 370
Alex S. Hartlage United States 8 191 1.4× 43 0.4× 203 1.9× 48 0.6× 33 0.6× 11 342
Jochen M. Wettengel Germany 12 360 2.7× 113 1.0× 233 2.2× 126 1.6× 51 0.9× 29 502
B Zheng China 10 188 1.4× 124 1.1× 85 0.8× 78 1.0× 59 1.0× 20 366
Helen Bright United Kingdom 11 277 2.1× 95 0.8× 62 0.6× 76 0.9× 30 0.5× 14 477
Ernest Adankwah Ghana 10 121 0.9× 144 1.2× 51 0.5× 30 0.4× 18 0.3× 26 279

Countries citing papers authored by Mehrdad Ravanshad

Since Specialization
Citations

This map shows the geographic impact of Mehrdad Ravanshad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Ravanshad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Ravanshad more than expected).

Fields of papers citing papers by Mehrdad Ravanshad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehrdad Ravanshad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Ravanshad. The network helps show where Mehrdad Ravanshad may publish in the future.

Co-authorship network of co-authors of Mehrdad Ravanshad

This figure shows the co-authorship network connecting the top 25 collaborators of Mehrdad Ravanshad. A scholar is included among the top collaborators of Mehrdad Ravanshad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehrdad Ravanshad. Mehrdad Ravanshad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fakhari, Zahra, Vahdat Poortahmasebi, Mohammad Farahmand, et al.. (2019). High prevalence of occult hepatitis B infection (OBI) among healthy children and their parents in Alborz province, Iran; Vertical OBI, myth or truth?. Liver International. 40(1). 92–100. 8 indexed citations
3.
Khanizadeh, Sayyad, et al.. (2017). The effect of the hepatitis C virus (HCV) NS3 protein on the expression of miR-150, miR-199a, miR-335, miR-194 and miR-27a. Microbial Pathogenesis. 110. 688–693. 17 indexed citations
4.
Ravanshad, Mehrdad, et al.. (2016). Phylogeny and drug resistance of HIV PR gene among HIV patients receiving RT inhibitors in Iran. Asian Pacific Journal of Tropical Biomedicine. 6(5). 451–454. 8 indexed citations
5.
Nasab, Seyed Dawood Mousavi, Farzaneh Sabahi, Manoochehr Makvandi, et al.. (2016). Epidemiology of Rotavirus-Norovirus Co-Infection and Determination of Norovirus Genogrouping among Children with Acute Gastroenteritis in Tehran, Iran.. PubMed. 20(5). 280–6. 22 indexed citations
6.
Gholami, Mohammad, et al.. (2016). Evaluation of miR-122 level in the plasma of chronically HCV infected patients. Molecular Biology. 50(2). 242–245. 2 indexed citations
7.
Gholami, Mohammad, et al.. (2016). Определение содержания miRNA-122 в плазме крови больных хроническим вирусным гепатитом C. Молекулярная биология. 50(2). 279–283. 4 indexed citations
8.
Ravanshad, Mehrdad, et al.. (2012). Drug resistance profile and subtyping of HIV-1 RT gene among Iranian under-treatment patients. Iranian Journal of Biotechnology. 10(1). 1–7. 4 indexed citations
9.
Ravanshad, Mehrdad, et al.. (2012). Application of Semi-nested PCR RFLP for Detection and Genotyping GBV-C among HBV-infected Patients. 15(1). 81–91. 1 indexed citations
10.
Ravanshad, Mehrdad, et al.. (2012). Survey of Human Immunodeficiency Virus-1 Protease Gene Drug Resistance among HIV-infected Patients in an Iranian Research Center for HIV/AIDS. 14(4). 14–21. 2 indexed citations
11.
Hosseini, Seyed Younes, et al.. (2012). Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes. Hepatitis Monthly. 12(9). e6130–e6130. 16 indexed citations
12.
Ravanshad, Mehrdad, et al.. (2011). Prediction of hepatitis B virus lamivudine resistance based on YMDD sequence data using an artificial neural network model. Hepatitis Monthly. 11(231). 108–113. 5 indexed citations
13.
Sabahi, Farzaneh, et al.. (2011). CLONING AND EVALUATION OF EXPRESSION OF A NOVEL OVERLAPPING REGION OF NS3 GENE OF HEPATITIS C VIRUS BY EXPRESSING VECTOR. 13(4). 21–32.
14.
Falahi, Shahab, et al.. (2010). Short Communication: SeroPrevalence of CMV in women’s with spontaneous abortion in kowsar hospital, Ilam during 2007-2008. 12(4). 39–43. 6 indexed citations
15.
Ravanshad, Mehrdad, et al.. (2010). DETECTION AND PREVALENCE OF POLYOMA VIRUS BK AMONG IRANIAN KIDNEY TRANSPLANT PATIENTS BY A NOVEL NESTED-PCR. Iranian Red Crescent Medical Journal. 12(6). 631–635. 3 indexed citations
16.
Ravanshad, Mehrdad, et al.. (2010). Phylogenetic analysis of HIV-1 pol gene (RT sequences) among Iranian HIV infected patients. Scientific Journal of Iran Blood Transfus Organ. 7(227). 94–100. 3 indexed citations
17.
18.
Ravanshad, Mehrdad, et al.. (2008). A novel sensitive multiplex RT-PCR ELISA method for detection of HIV-1/HCV co-infection. 11(12). 57–63. 1 indexed citations
19.
Ravanshad, Mehrdad, et al.. (2006). A RAPID MODIFIED ANTIBODY-CAPTURE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION HSV-1 PRIMARY INFECTION IN HUMAN. Shiraz E-Medical Journal. 7(2). 0–0.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumudu Narayana Breakdown of academic impact, for papers by Shahab Mahmoudvand Breakdown of academic impact, for papers by Peter D. Block Breakdown of academic impact, for papers by Nan L. Li Breakdown of academic impact, for papers by Sreedhar Chinnaswamy Breakdown of academic impact, for papers by Alex S. Hartlage Breakdown of academic impact, for papers by Jochen M. Wettengel Breakdown of academic impact, for papers by B Zheng Breakdown of academic impact, for papers by Helen Bright Breakdown of academic impact, for papers by Ernest Adankwah
Rankless by CCL
2026